Important pre-print study (but from a good team, including @florian_krammer), showing a single dose of a mRNA vaccine may provide superior protection to two doses, in people who’ve already had COVID-19. This could free up the vaccine supply, enabling more people to be vaccinated.
The researchers found that when people who’d previously been infected were given a single dose of a mRNA vaccine, their resulting antibody titres were 10-fold higher than people who hadn’t been infected, but received two doses of a mRNA vaccine.
The researchers also found the side effects of the vaccine were more pronounced in people who’d previously been infected (though none were serious).
Thus, if these people only need to be given a single dose of the vaccine, this could potentially save them unnecessary discomfort.
Ongoing study will be necessary to see whether the immunity resulting from a single dose is sustained, and also to see how it compares to people who’ve not been previously infected and received two standard doses of a mRNA vaccine.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
(1/6) This is quite a concerning development. An additional mutation (E484K; a key mutation in the South African variant) has now also been detected in a limited number of people infected with the UK variant.
Laboratory experiments suggest vaccine efficacy may be reduced.
(2/6) Here’s a nice figure from @K_G_Andersen, showing the different mutations in the UK, South African, & Brazilian variants.
E484K has now also appeared in multiple people in the UK, suggesting a process of convergent evolution. This means it’s likely to happen elsewhere, too.
(3/6) So far, this enhanced UK variant has been detected in 11 of 214,159 samples tested.
The E484K mutation previously appeared in a cluster of 32 cases of the original strain in Liverpool. bbc.com/news/health-55…
Case report of a hospital COVID-19 outbreak probably caused by airborne transmission. A child with an infected mother was admitted, after which 6 healthcare workers, 2 child patients, and 1 parent tested positive.
Three of the 6 healthcare workers had no direct contact with the mother or child and maintained a distance of approximately 2 metres during a ward round and dietician consultation. All 6 wore surgical masks. No aerosol-generating procedures were performed.
An additional 3 out of 4 contacts (2 child patients and one mother staying in the same room) tested positive. They were staying at a distance of more than 2 metres from one another, although brief contact over a shorter distance cannot be ruled out.
(1/7) Spectacular news from Novavax. The efficacy of their vaccine matches Pfizer & Moderna, but it doesn't have the same ultra-cold storage requirements. ❄️
UK phase 3 trial results:
95.6% original COVID-19
85.6% UK 🇬🇧 strain (#B117)
89.3% efficacy overall
(2/7) Importantly, the vaccine was tested in a large number of people (>15,000) in the UK, aged 18-84 years.
Almost a third (27%) were aged over 65 years.
(3/7) The company also announced results of a smaller phase 2 trial of their vaccine in South Africa (>4,400 people).
⚠️ Over 90% of cases that were detected in the trial were attributable to the South African variant, which did affect the vaccine's efficacy.
(2/5) The problem with the trial is that it only recruited 660 people aged >=65 years, and there was only one infection in the placebo group and one in the vaccine group in this age range.
This is almost certainly explained by chance, and doesn’t mean the vaccine didn’t work.
(3/5) Had there been more older people in the trial, there would likely have been more infections, and they would probably mostly have been in the placebo group, as occurred in younger people.
(1/17) Study of 2482 parents and 2482 children aged 1-10 years from Baden-Württemberg, Germany, showing that between 22 April and 15 May 2020, parents were more likely to have antibodies against SARS-CoV-2 than children (1.9% vs. 0.9%). jamanetwork.com/journals/jamap…
(2/17) In 56 families where at least one parent or child had antibodies, the combination of a positive parent and negative child was 4.3 times more likely than a positive child and negative parent.
(3/17) On the surface, this might sound like children are less susceptible to infection, and are less likely to transmit the virus than adults.
This is a genuine possibility, but I think there’s another, better explanation.
(2/6) But Australia’s an island, I hear you say. That’s true, and it certainly makes elimination easier. However, Australia had major outbreaks elsewhere.
The state of Victoria has recorded 20,433 cases & 820 deaths, mostly during a second wave in August. dhhs.vic.gov.au/victorian-coro…
(3/6) If unchecked, these outbreaks would have spread to the entire country. They didn’t because of internal border controls. Travel within Australia was restricted.
There is no reason why a similar red zone/green zone strategy couldn’t be implemented elsewhere. e.g., in Europe.